| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| « Jun | ||||||
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 | |||
A Faster Pathway to Drug Approvals
31 Jul 2010 03:30, The Motley Fool
... either. You only need to point to a drug such as Sanofi's obesity drug Acomplia, which was approved in Europe, but turned down in the U.S. because of psychiatric ...
New obesity compound shows promise in mice
26 Jul 2010 16:20, Reuters
... 26 (Reuters) - A compound similar to Sanofi-Aventis' ( ) once-promising weight loss drug Acomplia helped obese mice lose weight and lower their blood fats and blood sugar without ...
Click for the latest world news headlines from EIN News
Obesity drug shows promise in mice
26 Jul 2010 16:50, Seniors' Health
... CHICAGO - A compound similar to Sanofi-Aventis' once-promising weight loss drug Acomplia helped obese mice lose weight and lower their blood fats and blood sugar without ...
The UK National Institute for Health and Clinical Excellence (NICE) has approved the use of anti-obesity drug Acomplia (Rimonabant). The green light was given after the medication received positive appraisal from the institute in March.
Acomplia is recommended as an addition to exercise and proper diet for obese and overweight patients who found two other weight-loss medications Reductil (orlistat) and Xenical (sibutramine) ineffective. Now Acomplia can be prescribed by doctors from the state healthcare system of the UK. However, the drug still has to wait for approval in Germany and the United States. Sanofi-Aventis the manufacturer of Acomplia sais they expect that new clinical trials in Type 2 diabetes patients will influence the approval process.
continue reading "Acomplia Finally Gets OK for the UK"
Wordpress by DrugsPill.com